SOX9 Drives KRAS-Induced Lung Adenocarcinoma Progression and Suppresses Anti-Tumor Immunity

SRY-box transcription factor 9 (SOX9) consistently drove organoid growth in vitro, but SOX9-promoted tumor growth was significantly attenuated in immunocompromised mice compared to syngeneic mice.